Skip to content
Search

Latest Stories

PDA responds to NPA proposals for Day of Action, urges fair treatment for pharmacists

PDA responds to NPA proposals for Day of Action, urges fair treatment for pharmacists
"Employers must not adjust pharmacists' pay and schedules for day of action," the director of pharmacy, PDA, Jay Badenhorst says 

The Pharmacists' Defence Association (PDA) has written to the National Pharmacy Association (NPA) to highlight several important points regarding their proposed "day of action" on 20 June 2024.

The NPA describes this initiative as a response to the "emergency across the community pharmacy sector."


In a letter addressed to NPA Chair Nick Kaye and Chief Executive Paul Rees, the PDA's director of pharmacy, Jay Badenhorst stressed the need for NPA members to consider their obligations to staff and patients before participating in the planned actions.

He stated, "We are supportive of a new contractual framework for the community pharmacy sector."

"However, any actions taken must ensure the safety of patients and the operational integrity of pharmacies."

The PDA's letter also expressed concerns over the safety and operational impact of the proposed symbolic gestures, including turning off lights and blacking out windows.

The PDA emphasised that the Responsible Pharmacist (RP) has legal duties to ensure the safe operation of the pharmacy and should be able to exercise professional judgment without undue influence.

The organisation has urged the NPA to inform their members of these considerations to avoid potential disruptions and ensure the safety of patients.

While the proposed actions include symbolic gestures, one of the major concerns rasied by the defense association is the possibility that some NPA members might opt not to comply, potentially leading to pharmacy closures of up to two hours.

"Employee and locum pharmacists are not party to the contractual dispute between your members and NHS England, which has prompted the proposed day of action, and they should not come under pressure to participate," the letter said.

"Employers must not unilaterally adjust pharmacists’ normal pay and working patterns to accommodate this activity.

Likewise, any existing agreements on locum pay for that day must be honoured in line with the contract for services."

The PDA also firmly stated that employers must not unilaterally adjust pharmacists’ regular pay and work schedules to accommodate these activities.

Furthermore, any existing agreements on locum pay for that day must be upheld in accordance with contractual obligations.

Response to the NPA's "Save Our Pharmacies" day action

The National Pharmacy Association (NPA) is distributing new campaign materials to pharmacies across England to support its "Save Our Pharmacies" initiative ahead of the upcoming general election.

This campaign aims to highlight the financial pressures forcing pharmacies to close at an alarming rate.

NPA Chief Executive Paul Rees stated, "Pharmacies are under crushing financial pressure. We want to help them join our efforts to raise the profile of the funding crisis and make the public and politicians fully aware of the threat to our much-loved pharmacy network."

The campaign materials include posters, stickers, postcards for patients to send to MPs, and petition resources, designed to mobilise public support and influence policy makers and NHS managers to address the funding crisis.

The NPA revealed that 177 pharmacies closed between January and April 2024, a nearly 50 per cent increase from the same period last year.

The association is working with other pharmacy leaders to rally public support and create favorable conditions for successful contractual negotiations in England.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less